Founded in 1899, MIT Technology Review is one of the world's oldest technology magazines and one of the most influential think tanks on technology commercialization, building on the academic and industrial resources of the Massachusetts Institute of Technology (MIT).
MIT Technology Review China, the co-organizer of the conference, also focuses on technologies and fields that are disrupting the existing landscape and creating new market opportunities to impact human society, as well as technologies that are moving from the lab to the marketplace and will soon be commercialized.
Experts and scholars from Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Jiangnan University, Nanjing University of Technology, Shanghai University of Science and Technology, Tianjin University, Lanzhou University, and other universities and research institutes have gathered to give presentations to share cutting-edge research in synthetic biology.
As the representative of synthetic biology industrialization and co-organizer, ZHANG Zhiqian, Founder and CEO of Stage Creative Bio, will attend the conference and give a keynote speech to discuss the "synthetic biology platform and open co-creation of the industrialization of the path to break the ice" with the guests.
In addition, the conference will set up a roundtable sharing, industry, academia and research representatives will discuss "building a new ecology of synthetic biology industry".
Through platform capacity building, synthetic biology enterprises can provide diversified products and realize cross-industry coverage to meet different market demands, thus expanding market opportunities, improving enterprise competitiveness, avoiding the risk of industry cycle of a single species, and realizing business diversification and income diversification.
As one of the first enterprises in the industry to realize the integration of research, production and marketing, the layout of the whole industrial chain, and sustainable development, the synthetic biology platform of Strike Bio accelerates the process of industrialization based on technology, production, breakthroughs in products, and market orientation. External cooperation projects can be the fastest to achieve cooperation, landing and commercialization in the same year.
By opening up the upstream and downstream of the industrial chain, the Synthetic Biology Platform will continue to strengthen its ability to expand the whole chain and expand its global cooperation network, so that it can work closely with its partners to build a global synthetic biology industry ecosystem and move forward to the sustainable development of the "Bio-era".
Make a reservation now to join the "Platform accelerates industrialization and opens the new future of synthetic biology" online communication, inviting you to start the future together.